tyrphostin a9 has been researched along with Obesity in 1 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camacho, A | 1 |
| Segoviano-Ramírez, JC | 1 |
| Sánchez-Garcia, A | 1 |
| de Jesus Herrera-de la Rosa, J | 1 |
| García-Juarez, J | 1 |
| Hernandez-Puente, CA | 1 |
| Calvo-Anguiano, G | 1 |
| Maltos-Uro, SR | 1 |
| Olguin, A | 1 |
| Gojon-Romanillos, G | 1 |
| Gojon-Zorrilla, G | 1 |
| Ortiz-Lopez, R | 1 |
1 other study available for tyrphostin a9 and Obesity
| Article | Year |
|---|---|
Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro.
Topics: 3T3-L1 Cells; Adipocytes, White; Adipogenesis; Animals; Apoptosis; Diet, High-Fat; Lipid Metabolism; | 2018 |